These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 34405013)

  • 41. The prognostic effect of PNN in digestive tract cancers and its correlation with the tumor immune landscape in colon adenocarcinoma.
    Zhang H; Jin M; Ye M; Bei Y; Yang S; Liu K
    J Clin Lab Anal; 2022 Apr; 36(4):e24327. PubMed ID: 35257416
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Increased expression of GIPC2 in colon adenocarcinoma is associated with a favorable prognosis and high levels of immune cell infiltration.
    Kang M; Su Z
    Oncol Rep; 2023 Apr; 49(4):. PubMed ID: 36799193
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Elevated Ras related GTP binding B (RRAGB) expression predicts poor overall survival and constructs a prognostic nomogram for colon adenocarcinoma.
    Xiao J; Liu Q; Wu W; Yuan Y; Zhou J; Shi J; Zhou S
    Bioengineered; 2021 Dec; 12(1):4620-4632. PubMed ID: 34320917
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The YTH Domain Family of N6-Methyladenosine "Readers" in the Diagnosis and Prognosis of Colonic Adenocarcinoma.
    Xu D; Shao J; Song H; Wang J
    Biomed Res Int; 2020; 2020():9502560. PubMed ID: 32596399
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Overexpression of Sine Oculis Homeobox Homolog 2 Predicts Poor Survival and Clinical Parameters of Patients with Colon Adenocarcinoma.
    Jiang Y; Zhou B; Liang B; Zeng F; Zou Z
    Ann Clin Lab Sci; 2020 Nov; 50(6):717-725. PubMed ID: 33334785
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The diagnosis and prognosis values of WNT mRNA expression in colon adenocarcinoma.
    Ruan GT; Zhu LC; Gong YZ; Liao XW; Wang XK; Liao C; Wang S; Yan L; Xie HL; Zhou X; Li YZ; Gao F
    J Cell Biochem; 2020 Jun; 121(5-6):3145-3161. PubMed ID: 31886580
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Diagnostic and prognostic values of forkhead box D4 gene in colonic adenocarcinoma.
    Li QX; Li NQ; Liao JY
    Int J Clin Exp Pathol; 2020; 13(10):2615-2627. PubMed ID: 33165349
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Copper metabolism patterns and tumor microenvironment characterization in colon adenocarcinoma.
    Lin J; Luo B; Yu X; Yang Z; Wang M; Cai W
    Front Oncol; 2022; 12():959273. PubMed ID: 36203457
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Nuclear receptor subfamily 3 group c member 2 (NR3C2) is downregulated due to hypermethylation and plays a tumor-suppressive role in colon cancer.
    Li X; Yang A; Wen P; Yuan Y; Xiao Z; Shi H; Wang R
    Mol Cell Biochem; 2022 Nov; 477(11):2669-2679. PubMed ID: 35604518
    [TBL] [Abstract][Full Text] [Related]  

  • 50.
    Liu L; Jia S; Jin X; Zhu S; Zhang S
    DNA Cell Biol; 2021 Sep; 40(9):1158-1166. PubMed ID: 34415792
    [TBL] [Abstract][Full Text] [Related]  

  • 51. ISYNA1: An Immunomodulatory-Related Prognostic Biomarker in Colon Adenocarcinoma and Pan-Cancer.
    Jia Z; Wan X
    Front Cell Dev Biol; 2022; 10():792564. PubMed ID: 35237596
    [No Abstract]   [Full Text] [Related]  

  • 52. Comprehensive analysis of the correlation between GSTM1 and tumor immunity in colon cancer.
    Luo HY; Tang WL; Xiang L; Peng LL; Wu DB; Zhu ZY; Gu HT; Tang YH; Perkins RS; Shen HY; Wang YX
    J Gastrointest Oncol; 2022 Dec; 13(6):3025-3037. PubMed ID: 36636093
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Identification of Transcription Factor-Related Gene Signature and Risk Score Model for Colon Adenocarcinoma.
    Lin J; Cao Z; Yu D; Cai W
    Front Genet; 2021; 12():709133. PubMed ID: 34603375
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Prognostic value of a novel glycolysis-related gene expression signature for gastrointestinal cancer in the Asian population.
    Xia R; Tang H; Shen J; Xu S; Liang Y; Zhang Y; Gong X; Min Y; Zhang D; Tao C; Wang S; Zhang Y; Yang J; Wang C
    Cancer Cell Int; 2021 Mar; 21(1):154. PubMed ID: 33663535
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Mining novel cell glycolysis related gene markers that can predict the survival of colon adenocarcinoma patients.
    Chen S; Cao G; Wu W; Lu Y; He X; Yang L; Chen K; Chen B; Xiong M
    Biosci Rep; 2020 Aug; 40(8):. PubMed ID: 32744303
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Investigation of
    Yavari S; Naseroleslami M; Peymani M; Yekani F; Khayam Nekouei N
    Cell J; 2024 Jul; 26(5):309-319. PubMed ID: 39066595
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Discovered differentially expressed lncRNA AC010973.2 can act as a diagnostic and prognostic biomarker for colon adenocarcinoma.
    Liu X; Xiao C; Tan F; Yi R; Zhao X
    Transl Cancer Res; 2020 Oct; 9(10):6275-6286. PubMed ID: 35117237
    [TBL] [Abstract][Full Text] [Related]  

  • 58. A glycolysis-related two-gene risk model that can effectively predict the prognosis of patients with rectal cancer.
    Liu Z; Liu Z; Zhou X; Lu Y; Yao Y; Wang W; Lu S; Wang B; Li F; Fu W
    Hum Genomics; 2022 Feb; 16(1):5. PubMed ID: 35109912
    [TBL] [Abstract][Full Text] [Related]  

  • 59.
    Yang Z; Wu H; Dai D; Yuan Y; Shao X
    Iran J Public Health; 2023 Dec; 52(12):2601-2610. PubMed ID: 38435777
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Prediction and identification of immune genes related to the prognosis of patients with colon adenocarcinoma and its mechanisms.
    Chen S; Cao GD; Wei W; Yida L; Xiaobo H; Lei Y; Ke C; Chen B; Xiong MM
    World J Surg Oncol; 2020 Jun; 18(1):146. PubMed ID: 32600423
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.